Wednesday, 26 January 2022

PharmEasy aims to vaccinate over 3 Cr people

26 April 2021 | News

Initiates India’s largest COVID-19 vaccination drive

Image credit- shutterstock.com

Image credit- shutterstock.com

PharmEasy, a part of API Holdings, has launched the biggest COVID-19 vaccination drive in the country. With this drive, the company aims to vaccinate over 3 crore people via camps and vaccine centres. Individuals, companies, RWAs, Old Age Homes etc. can register for vaccines that will be administered.

India has witnessed a record rise in COVID-19 cases due to the second wave, surpassing the worst of last year. Given the current situation, the Government of India has invited the participation of private companies to accelerate vaccination across the country. From 1st May 2021, wherein all legal adults (above the age of 18) will be eligible to get vaccinated against COVID-19.

Leveraging its presence across India, with over 80,000 partner retailers, 5,000 doctors and a state-of-the-art pharma supply chain facility enabling last-mile delivery of cold chain products, the company aims to vaccinate over 3 crore families via 5,000 partner centres, pan-India in the next few quarters. 

Basis the availability of vaccines and guidelines provided by GOI (to be released soon), PharmEasy will release the timelines for the start of the vaccination drive. As soon as the vaccines doses are available, the company will reach out to registered individuals and assist them with vaccination slots at camps set-up in their vicinity.

Speaking about the vaccination drive, Dharmil Sheth, Co-founder, PharmEasy said, “We want to be a vital part of the government’s vaccination drive and help accelerate the process of mass vaccination. Our vaccination drive aims to provide ease of access to vaccination which can help us to achieve herd immunity at the earliest. Amidst the rising COVID-19 cases in the second wave, we wanted to contribute our bit in breaking the chain by setting up vaccination camps and centres to facilitate this.”

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account